Russo et al. found decreased DPPIV mRNA and protein levels in patients with castrate-resistant prostate cancer, and DPPIV inhibition with sitagliptin enhanced prostate cancer xenografts growth after castration. Here, DPP4 is linked to Familial prostate cancer.